Activation of Endothelial Cells in Conduit Veins of Dogs With Heart Failure and Veins of Normal Dogs After Vascular Stretch by Acute Volume Loading

Journal of Cardiac Failure

Volumn 15, Issue 5, 2009, Pages 457-463

  Colombo, Paolo C ^a   Rastogi, Sharad ^b   Onat, Duygu ^a   Zacà, Valerio ^b   Gupta, Ramesh C ^b   Jorde, Ulrich P ^a   Sabbah, Hani N ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

endothelium; Heart failure; inflammation

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; NEUROHORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL DOG; GENE SEQUENCE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; JUGULAR VEIN; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOOD VOLUME; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; INTERLEUKIN-6; JUGULAR VEINS; POLYMERASE CHAIN REACTION; RNA; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 67349244389     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.12.006     Document Type: Article

References (63)

1. Sumpio B.E., Riley J.T., and Dardik A. Cells in focus: endothelial cell. Int J Biochem Cell Biol 34 (2002) 1508-1512
2. Aird W.C. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98 (2006) 159-162
3. Gimbrone Jr. M.A., Topper J.N., Nagel T., Anderson K.R., and Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902 (2000) 230-239 discussion 239-40
4. Katz S.D., Biasucci L., Sabba C., Strom J.A., Jondeau G., Galvao M., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19 (1992) 918-925
5. Dzeka T.N., and Arnold J.M. Prostaglandin modulation of venoconstriction to physiological stress in normals and heart failure patients. Am J Physiol Heart Circ Physiol 284 (2003) H790-H797
6. Katz S.D., Hryniewicz K., Hriljac I., Balidemaj K., Dimayuga C., Hudaihed A., et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111 (2005) 310-314
7. Pang C.C. Measurement of body venous tone. J Pharmacol Toxicol Methods 44 (2000) 341-360
8. Firth J.D., Raine A.E., and Ledingham J.G. Raised venous pressure: a direct cause of renal sodium retention in oedema?. Lancet 1 (1988) 1033-1035
9. Blake W.D., Wegria R., et al. Effect of increased renal venous pressure on renal function. Am J Physiol 157 (1949) 1-13
10. Vane J.R., Anggard E.E., and Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med 323 (1990) 27-36
11. Esmon C.T. Crosstalk between inflammation and thrombosis. Maturitas 47 (2004) 305-314
12. Colombo P.C., Ashton A.W., Celaj S., Talreja A., Banchs J.E., Dubois N.B., et al. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J Appl Physiol 92 (2002) 1331-1338
13. Colombo P.C., Banchs J.E., Celaj S., Talreja A., Lachmann J., Malla S., et al. Endothelial cell activation in patients with decompensated heart failure. Circulation 111 (2005) 58-62
14. Cotter G., Moshkovitz Y., Milovanov O., Salah A., Blatt A., Krakover R., et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 4 (2002) 227-234
15. Gheorghiade M., De Luca L., Fonarow G.C., Filippatos G., Metra M., and Francis G.S. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 96 (2005) 11G-17G
16. White M., Ducharme A., Ibrahim R., Whittom L., Lavoie J., Guertin M.C., et al. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) 110 (2006) 483-489
17. Sabbah H.N., Stein P.D., Kono T., Gheorghiade M., Levine T.B., Jafri S., et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260 (1991) H1379-H1384
18. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., and Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169 (1989) 333-338
19. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 11 (1990) 443-449
20. Bonow R.O. New insights into the cardiac natriuretic peptides. Circulation 93 (1996) 1946-1950
21. Kema I.P., de Vries E.G., Slooff M.J., Biesma B., and Muskiet F.A. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin Chem 40 (1994) 86-95
22. Yndestad A., Holm A.M., Muller F., Simonsen S., Froland S.S., Gullestad L., et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 60 (2003) 141-146
23. Kaneko K., Kanda T., Yamauchi Y., Hasegawa A., Iwasaki T., Arai M., et al. C-Reactive protein in dilated cardiomyopathy. Cardiology 91 (1999) 215-219
24. McMurray J., Chopra M., Abdullah I., Smith W.E., and Dargie H.J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14 (1993) 1493-1498
25. Gupta R., Imai M., Alice J., Jiang A., Wang J., and Sabbah H. Chronic therapy with selective electric vagus nerve stimulation normalizes plasma concentration of tissue necrosis factor-α, interleukin-6 and B-type natriuretic peptide in dogs with heart failure. Am Coll Cardiol (2006) A-335172
26. Pober J.S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 131 (1987) 170-184
27. Goldin A., Beckman J.A., Schmidt A.M., and Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114 (2006) 597-605
28. Hartog J.W., Voors A.A., Schalkwijk C.G., Scheijen J., Smilde T.D., Damman K., et al. Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J 28 (2007) 2879-2885
29. Jorde U.P., Colombo P.C., Ahuja K., Hudaihed A., Onat D., Diaz T., et al. Exercise-induced increases in oxidized low-density lipoprotein are associated with adverse outcomes in chronic heart failure. J Card Fail 13 (2007) 759-764
30. Guzik T.J., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54 (2003) 469-487
31. Madge L.A., and Pober J.S. TNF signaling in vascular endothelial cells. Exp Mol Pathol 70 (2001) 317-325
32. Mehta J.L. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. Can J Cardiol 20 (2004) Suppl B:32B-6B
33. Ungvari Z., Wolin M.S., and Csiszar A. Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling?. Antioxid Redox Signal 8 (2006) 1121-1129
34. Canty Jr. T.G., Boyle Jr. E.M., Farr A., Morgan E.N., Verrier E.D., and Pohlman T.H. Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha. Circulation 100 (1999) II361-II364
35. Ungvari Z., Csiszar A., Edwards J.G., Kaminski P.M., Wolin M.S., Kaley G., et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23 (2003) 418-424
36. Freixes M., Rodriguez A., Dalfo E., and Ferrer I. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 27 (2006) 1807-1815
37. Mark K.S., Trickler W.J., and Miller D.W. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 297 (2001) 1051-1058
38. Cosentino F., Eto M., De Paolis P., van der Loo B., Bachschmid M., Ullrich V., et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107 (2003) 1017-1023
39. Huang S.M., Wu C.H., and Yen G.C. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol Nutr Food Res 50 (2006) 1129-1139
40. Hung T.H., Charnock-Jones D.S., Skepper J.N., and Burton G.J. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164 (2004) 1049-1061
41. Slupsky J.R., Kalbas M., Willuweit A., Henn V., Kroczek R.A., and Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80 (1998) 1008-1014
42. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95 (2004) 233-238
43. Yamagishi S., Fujimori H., Yonekura H., Yamamoto Y., and Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41 (1998) 1435-1441
44. Singh U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25 (2005) 151-174
45. Gheorghiade M., Zannad F., Sopko G., Klein L., Pina I.L., Konstam M.A., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
46. Kim S.F., Huri D.A., and Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310 (2005) 1966-1970
47. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
48. Moens A.L., and Kass D.A. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26 (2006) 2439-2444
49. Wells S.M., and Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 36 (2007) 520-528
50. Feng Q., Lu X., Fortin A.J., Pettersson A., Hedner T., Kline R.L., et al. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovasc Res 37 (1998) 667-675
51. Yamagishi S., Inagaki Y., and Kikuchi S. Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation. Drugs Exp Clin Res 29 (2003) 147-152
52. Basta G., Lazzerini G., Del Turco S., Ratto G.M., Schmidt A.M., and De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 25 (2005) 1401-1407
53. Sanguigni V., Ferro D., Pignatelli P., Del Ben M., Nadia T., Saliola M., et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 45 (2005) 35-42
54. Ennezat P.V., Malendowicz S.L., Testa M., Colombo P.C., Cohen-Solal A., Evans T., et al. Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes. J Am Coll Cardiol 38 (2001) 194-198
55. Campese V.M., Sindhu R.K., Ye S., Bai Y., Vaziri N.D., and Jabbari B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res 1134 (2007) 27-32
56. Feng N.H., Chu S.J., Wang D., Hsu K., Lin C.H., and Lin H.I. Effects of various antioxidants on endotoxin-induced lung injury and gene expression: mRNA expressions of MnSOD, interleukin-1beta and iNOS. Chin J Physiol 47 (2004) 111-120
57. Chong A.Y., and Lip G.Y. Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?. Eur J Heart Fail 9 (2007) 124-128
58. Howell M.D., Geraci J.M., and Knowlton A.A. Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 54 (2001) 810-816
59. Yu C.M., Wang L., Chau E., Chan R.H., Kong S.L., Tang M.O., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
60. Adamson P.B., Magalski A., Braunschweig F., Bohm M., Reynolds D., Steinhaus D., et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41 (2003) 565-571
61. Hasdai D., Holmes Jr. D.R., Garratt K.N., Edwards W.D., and Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 95 (1997) 357-362
62. Kawai M., Naruse K., Komatsu S., Kobayashi S., Nagino M., Nimura Y., et al. Mechanical stress-dependent secretion of interleukin 6 by endothelial cells after portal vein embolization: clinical and experimental studies. J Hepatol 37 (2002) 240-246
63. Wang B.W., Chang H., Lin S., Kuan P., and Shyu K.G. Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells. Cardiovasc Res 59 (2003) 460-469